Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study

Refrences

• Li G, Fan L, Zhang L, Zhang W, Huang X. Metabolic parameters and perinatal outcomes of gestational diabetes mellitus in women with polycystic ovary syndrome. J Perinat Med 2010 Mar;38(2):141–146. Erratum in: J Perinat Med 2010 May;38(3):343.
   Google Scholar
• Balen A. Polycystic ovary syndrome and cancer. Human Reprod Update 2001;7:522–525.
   PubMed Web of Science ®Google Scholar
• Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004;59(2):141–154.
   PubMed Web of Science ®Google Scholar
• Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. Meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12:673–683.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Australian carbohydrate intolerance study in pregnant women (ACHOIS) trial group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352(24):2477–2486.
   PubMed Web of Science ®Google Scholar
• Vollenhoven B, Clark S, Kovacs G, Burger H, Healy D. Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins. Aust N Z J Obstet Gynecol 2000;40:54–58.
   Google Scholar
• Persson B, Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 1998;21(Suppl. 2):B113–B117.
   Google Scholar
• Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001;16:226–229.
   PubMed Web of Science ®Google Scholar
• Vrbikova J, Bendlova B, Hill M, Vondra K, Starka L. Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome. Diabetes Care 2002;25:1217–1222.
   PubMed Web of Science ®Google Scholar
• Schachter M, Raziel A, Friedler S, Strassburger D, Bern O, Ron-El R. Insulin resistances in patients with polycystic ovary syndrome is associated with elevated plasma homocystiene. Hum Reprod 2003;18:721–727.
   PubMed Web of Science ®Google Scholar
• Turhan NO, Seckin NC, Aybar F, Inegol I. Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients. Int J Gynaecol Obstet 2003;81:163–168.
   PubMed Web of Science ®Google Scholar
• Randon PA, McMahon MJ, Meyer WR. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Diabetologia 1998;94:194–197.
   Google Scholar
• Paradisi G, Fulghesu AM, Ferrazzani S, Moretti S, Proto C, Soranna L, Caruso A, Lanzone A. Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy. Hum Reprod 1998;13:542–546.
   Google Scholar
• Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Human Reprod 2002a;17: 2858–2864.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Goldeberg N, Streicher P, Wang P. The contentious nature of gestational diabetes: diet, insulin, glyburide and metformin. Expert Opin Pharmacother 2002 b;3:1557–1568.
   PubMedGoogle Scholar
• Glueck CJ, Streicher P, Wang P. Treatment of polycystic syndrome with insulin – lowering agents. Expert Opin Pharmacother 2002c;3:1177–1189.
   PubMedGoogle Scholar
• Glueck CJ, Wang P, Goldeberg N and Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Human Reprod 2002d;17: 2858–2864.
   PubMed Web of Science ®Google Scholar
• Galtier-Dereure F, Boegner C, Bringer J. Obesity and pregnancy complications and cost. Am J Clin 2000;71: 1242S–1248S.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Goldenberg N, Wang P, Loftspring M, Sherman A. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 2004;19: 510–521.
   PubMed Web of Science ®Google Scholar
• Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 2006;86:658–663.
   PubMed Web of Science ®Google Scholar
• Khattab S, Mohsen IA, Foutouh IA, Ramadan A, Moaz M, Al-Inany H. Metformin reduces abortion in pregnant women with polycystic ovary syndrome. Gynecol Endocrinol 2006;22: 680–684.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 2001;75:46–52.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Sieve L, Zhu B, Wang P. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome. Metabolism 2006;55: 345–352.
   PubMed Web of Science ®Google Scholar
• Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87(2):524–529.
   PubMedGoogle Scholar
• Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004;l.19(8):1734–1740.
   Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2003;81:19–25, 2004.
   Web of Science ®Google Scholar
• World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation Group. 1998.
   Google Scholar
• Homburg R. Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metab 2006;20(2):281–292.
   PubMed Web of Science ®Google Scholar
• Begum MR, Khanam NN, Quadir E, Ferdous J, Begum MS, Khan F, Begum A. Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome. J Obstet Gynaecol Res 2009;35(2):282–286.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Pranikoff J, Aregawi D, Wang P. Prevention of gestational diabetes by metformin plus diet in patients with polcystic ovary syndrome. Fertil Steril 2008;89(3):625–634.
   PubMed Web of Science ®Google Scholar
• Nawaz FH, Rizvi J. Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome. Gynecol Obstet Invest 2010;69(3):184–189.
   PubMed Web of Science ®Google Scholar
• Bolton S, Cleary B, Walsh J, Dempsey E, Turner MJ. Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity. Eur J Pediatr 2009;168(2): 203–206.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Economou FN. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. Eur J Endocrinol 2010; 162(2):193–212.
   PubMed Web of Science ®Google Scholar
• Coetzee EJ, Jackson WP. Oral hypoglycaemics in the first trimester and fetal outcome. S Afr Med J 1984;65:635–637.
   PubMed Web of Science ®Google Scholar